Loading data
BCYCNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 72.59 m USD | 35.28 m USD | 26.98 m USD | 14.46 m USD | 11.7 m USD |
| Research and development expense | 240.28 m USD | 172.97 m USD | 156.5 m USD | 81.61 m USD | 44.88 m USD |
| Operating profit | -247.07 m USD | -209.87 m USD | -189.95 m USD | -116.65 m USD | -65.62 m USD |
| Interest expense | — | — | 3.26 m USD | 3.34 m USD | 2.98 m USD |
| Profit before tax | -218.81 m USD | -173.8 m USD | -179.21 m USD | -114.24 m USD | -68.48 m USD |
| Income tax expense | 152 k USD | -4.77 m USD | 1.5 m USD | -1.5 m USD | -1.66 m USD |
| Net income (reported basis) | -218.96 m USD | -169.03 m USD | -180.66 m USD | -112.72 m USD | -66.82 m USD |
| Net income attributable to common shareholders | -218.96 m USD | -169.03 m USD | -180.66 m USD | -112.72 m USD | -66.82 m USD |
| Basic earnings per share | -3.16 USD/share | -2.9 USD/share | -5.08 USD/share | -3.8 USD/share | -2.67 USD/share |
| Diluted earnings per share | -3.16 USD/share | -2.9 USD/share | -5.08 USD/share | -3.8 USD/share | -2.67 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.